Literature DB >> 17323346

Hemispherectomy for intractable epilepsy in adults: the first reported series.

Shearwood McClelland1, Robert E Maxwell.   

Abstract

Hemispherectomy for intractable unihemispheric epilepsy (IUE) has long been established in pediatric patients. This study reports the first series examining hemispherectomy exclusively in adult patients (>18 years old). Nine adults with IUE underwent hemispherectomy at the University of Minnesota. All patients had unilateral hemiplegia and visual field loss. Seven patients (77.8%) were Engel class I/II at last follow-up. Five (83.3%) of the six patients with >30 years of follow-up were seizure free. No surgery-related mortality, hydrocephalus, or superficial cerebral hemosiderosis occurred. Hemispherectomy is an effective procedure in appropriately selected adult patients, resulting in excellent long-term seizure control and no mortality.

Entities:  

Mesh:

Year:  2007        PMID: 17323346     DOI: 10.1002/ana.21084

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  4 in total

1.  Occult hemispherectomy: an unusual finding at autopsy.

Authors:  René Gapert; Navena Widulin; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2012-06-30       Impact factor: 2.007

2.  Hemispherectomy in adults and adolescents: Seizure and functional outcomes in 47 patients.

Authors:  Robert A McGovern; Ahsan N V Moosa; Lara Jehi; Robyn Busch; Lisa Ferguson; Ajay Gupta; Jorge Gonzalez-Martinez; Elaine Wyllie; Imad Najm; William E Bingaman
Journal:  Epilepsia       Date:  2019-11-02       Impact factor: 5.864

3.  Evolution of epilepsy in hemimegalencephaly from infancy to adulthood: Case report and review of the literature.

Authors:  Kristin M Ikeda; Seyed M Mirsattari
Journal:  Epilepsy Behav Case Rep       Date:  2017-03-01

4.  Comprehensive analysis of neonatal versus adult unilateral decortication in a mouse model using behavioral, neuroanatomical, and DNA microarray approaches.

Authors:  Akira Yoshikawa; Tomoya Nakamachi; Junko Shibato; Randeep Rakwal; Seiji Shioda
Journal:  Int J Mol Sci       Date:  2014-12-05       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.